483 related articles for article (PubMed ID: 17063122)
41. Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses.
Warncke M; Dodero A; Dierbach H; Follo M; Veelken H
J Immunol Methods; 2006 Mar; 310(1-2):1-11. PubMed ID: 16337648
[TBL] [Abstract][Full Text] [Related]
42. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.
Schlienger K; Chu CS; Woo EY; Rivers PM; Toll AJ; Hudson B; Maus MV; Riley JL; Choi Y; Coukos G; Kaiser LR; Rubin SC; Levine BL; Carroll RG; June CH
Clin Cancer Res; 2003 Apr; 9(4):1517-27. PubMed ID: 12684428
[TBL] [Abstract][Full Text] [Related]
43. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes for use in cancer immunotherapy.
Ozaki Y; Kontani K; Teramoto K; Fujita T; Tezuka N; Sawai S; Watanabe H; Fujino S; Asai T; Ohkubo I
Biochem Biophys Res Commun; 2004 May; 317(4):1089-95. PubMed ID: 15094380
[TBL] [Abstract][Full Text] [Related]
44. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
Hetttihewa LM
Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
[TBL] [Abstract][Full Text] [Related]
45. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
[TBL] [Abstract][Full Text] [Related]
46. Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells.
Galetto A; Contarini M; Sapino A; Cassoni P; Consalvo E; Forno S; Pezzi C; Barnaba V; Mussa A; Matera L
J Surg Res; 2001 Sep; 100(1):32-8. PubMed ID: 11516202
[TBL] [Abstract][Full Text] [Related]
47. Ex vivo expansion of antitumor cytotoxic lymphocytes with tumor-associated antigen-loaded dendritic cells.
Gervais A; Bouet-Toussaint F; Toutirais O; De La Pintiere CT; Genetet N; Catros-Quemener V
Anticancer Res; 2005; 25(3B):2177-85. PubMed ID: 16158961
[TBL] [Abstract][Full Text] [Related]
48. Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsets.
Dalgaard J; Beckstrøm KJ; Jahnsen FL; Brinchmann JE
J Leukoc Biol; 2005 May; 77(5):689-98. PubMed ID: 15728242
[TBL] [Abstract][Full Text] [Related]
49. Transgene expression in dendritic cells to induce antigen-specific cytotoxic T cells in healthy donors.
Philip R; Brunette E; Ashton J; Alters S; Gadea J; Sorich M; Yau J; O'Donoghue G; Lebkowski J; Okarma T; Philip M
Cancer Gene Ther; 1998; 5(4):236-46. PubMed ID: 9694075
[TBL] [Abstract][Full Text] [Related]
50. Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells.
Elkord E; Williams PE; Kynaston H; Rowbottom AW
Immunology; 2005 Feb; 114(2):204-12. PubMed ID: 15667565
[TBL] [Abstract][Full Text] [Related]
51. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
Moldenhauer A; Frank RC; Pinilla-Ibarz J; Holland G; Boccuni P; Scheinberg DA; Salama A; Seeger K; Moore MA; Nimer SD
J Leukoc Biol; 2004 Sep; 76(3):623-33. PubMed ID: 15197237
[TBL] [Abstract][Full Text] [Related]
52. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
[TBL] [Abstract][Full Text] [Related]
53. Double-stranded RNA stimulation or CD40 ligation of monocyte-derived dendritic cells as models to study their activation and maturation process.
Megiovanni AM; Sanchez F; Gluckman JC; Rosenzwajg M
Eur Cytokine Netw; 2004; 15(2):126-34. PubMed ID: 15319172
[TBL] [Abstract][Full Text] [Related]
54. Characterization of dendritic-like cells derived from t(9;22) acute lymphoblastic leukemia blasts.
Lee J; Sait SN; Wetzler M
Int Immunol; 2004 Oct; 16(10):1377-89. PubMed ID: 15302850
[TBL] [Abstract][Full Text] [Related]
55. Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells.
Liu KJ; Lu LF; Cheng HT; Hung YM; Shiou SR; Whang-Peng J; Juang SH
Cancer Gene Ther; 2004 Feb; 11(2):135-47. PubMed ID: 14647233
[TBL] [Abstract][Full Text] [Related]
56. [In vitro effect on the differentiation and maturation of monocyte-derived dendritic cells by mannan-binding lectin].
Chen Y; Chen ZL; Zuo DM; Qiu YG; Zhang LY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):159-62. PubMed ID: 15766398
[TBL] [Abstract][Full Text] [Related]
57. Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes.
Grünebach F; Kayser K; Weck MM; Müller MR; Appel S; Brossart P
Cancer Gene Ther; 2005 Sep; 12(9):749-56. PubMed ID: 15877082
[TBL] [Abstract][Full Text] [Related]
58. [In vitro studies on dendritic cell derived from cord blood and its role in antitumor immunity].
Liu Y; Zhu M; Zhang H
Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):352-5. PubMed ID: 11776177
[TBL] [Abstract][Full Text] [Related]
59. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes.
Strobel I; Berchtold S; Götze A; Schulze U; Schuler G; Steinkasserer A
Gene Ther; 2000 Dec; 7(23):2028-35. PubMed ID: 11175315
[TBL] [Abstract][Full Text] [Related]
60. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy.
Waeckerle-Men Y; Scandella E; Uetz-Von Allmen E; Ludewig B; Gillessen S; Merkle HP; Gander B; Groettrup M
J Immunol Methods; 2004 Apr; 287(1-2):109-24. PubMed ID: 15099760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
